Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 78

1.

CCR7 Sulfotyrosine Enhances CCL21 Binding.

Phillips AJ, Taleski D, Koplinski CA, Getschman AE, Moussouras NA, Richard AM, Peterson FC, Dwinell MB, Volkman BF, Payne RJ, Veldkamp CT.

Int J Mol Sci. 2017 Aug 25;18(9). pii: E1857. doi: 10.3390/ijms18091857.

2.

Biased agonism and allosteric modulation of G protein-coupled receptor 183 - a 7TM receptor also known as Epstein-Barr virus-induced gene 2.

Daugvilaite V, Madsen CM, Lückmann M, Echeverria CC, Sailer AW, Frimurer TM, Rosenkilde MM, Benned-Jensen T.

Br J Pharmacol. 2017 Jul;174(13):2031-2042. doi: 10.1111/bph.13801. Epub 2017 May 4.

PMID:
28369721
3.

Novel Chemokine-Based Immunotoxins for Potent and Selective Targeting of Cytomegalovirus Infected Cells.

Spiess K, Jeppesen MG, Malmgaard-Clausen M, Krzywkowski K, Kledal TN, Rosenkilde MM.

J Immunol Res. 2017;2017:4069260. doi: 10.1155/2017/4069260. Epub 2017 Jan 30.

4.

Myeloid cells pave the way for lymphatic system development and maintenance.

Ivanov S, Randolph GJ.

Pflugers Arch. 2017 Apr;469(3-4):465-472. doi: 10.1007/s00424-017-1951-9. Epub 2017 Feb 20. Review.

5.

EBI2 overexpression in mice leads to B1 B-cell expansion and chronic lymphocytic leukemia-like B-cell malignancies.

Niss Arfelt K, Barington L, Benned-Jensen T, Kubale V, Kovalchuk AL, Daugvilaite V, Christensen JP, Thomsen AR, Egerod KL, Bassi MR, Spiess K, Schwartz TW, Wang H, Morse HC 3rd, Holst PJ, Rosenkilde MM.

Blood. 2017 Feb 16;129(7):866-878. doi: 10.1182/blood-2016-02-697185. Epub 2016 Dec 21.

6.

The EBI2 signalling pathway plays a role in cellular crosstalk between astrocytes and macrophages.

Rutkowska A, O'Sullivan SA, Christen I, Zhang J, Sailer AW, Dev KK.

Sci Rep. 2016 May 11;6:25520. doi: 10.1038/srep25520.

7.

CD4+CD25+Foxp3+ T regulatory cells, Th1 (CCR5, IL-2, IFN-γ) and Th2 (CCR4, IL-4, Il-13) type chemokine receptors and intracellular cytokines in children with common variable immunodeficiency.

Kutukculer N, Azarsiz E, Aksu G, Karaca NE.

Int J Immunopathol Pharmacol. 2016 Jun;29(2):241-51. doi: 10.1177/0394632015617064. Epub 2015 Dec 18.

8.

Proteoglycan expression correlates with the phenotype of malignant and non-malignant EBV-positive B-cell lines.

Tsidulko AY, Matskova L, Astakhova LA, Ernberg I, Grigorieva EV.

Oncotarget. 2015 Dec 22;6(41):43529-39. doi: 10.18632/oncotarget.5984.

9.

EBV Persistence--Introducing the Virus.

Thorley-Lawson DA.

Curr Top Microbiol Immunol. 2015;390(Pt 1):151-209. doi: 10.1007/978-3-319-22822-8_8. Review.

10.

Proteomics and Transcriptomics of BJAB Cells Expressing the Epstein-Barr Virus Noncoding RNAs EBER1 and EBER2.

Pimienta G, Fok V, Haslip M, Nagy M, Takyar S, Steitz JA.

PLoS One. 2015 Jun 29;10(6):e0124638. doi: 10.1371/journal.pone.0124638. eCollection 2015.

11.

7α, 25-dihydroxycholesterol-mediated activation of EBI2 in immune regulation and diseases.

Sun S, Liu C.

Front Pharmacol. 2015 Mar 24;6:60. doi: 10.3389/fphar.2015.00060. eCollection 2015. Review.

12.

Epstein-Barr virus latent genes.

Kang MS, Kieff E.

Exp Mol Med. 2015 Jan 23;47:e131. doi: 10.1038/emm.2014.84. Review.

13.

Oxysterol-EBI2 signaling in immune regulation and viral infection.

Daugvilaite V, Arfelt KN, Benned-Jensen T, Sailer AW, Rosenkilde MM.

Eur J Immunol. 2014 Jul;44(7):1904-12. doi: 10.1002/eji.201444493. Epub 2014 Jun 20. Review.

14.

CC-Chemokine receptor CCR7: a key molecule for lymph node metastasis in esophageal squamous cell carcinoma.

Irino T, Takeuchi H, Matsuda S, Saikawa Y, Kawakubo H, Wada N, Takahashi T, Nakamura R, Fukuda K, Omori T, Kitagawa Y.

BMC Cancer. 2014 Apr 26;14:291. doi: 10.1186/1471-2407-14-291.

15.

The chemokine receptor CCR7 expressed by dendritic cells: a key player in corneal and ocular surface inflammation.

Saban DR.

Ocul Surf. 2014 Apr;12(2):87-99. doi: 10.1016/j.jtos.2013.10.007. Epub 2013 Dec 31. Review.

16.

Small molecule antagonism of oxysterol-induced Epstein-Barr virus induced gene 2 (EBI2) activation.

Benned-Jensen T, Madsen CM, Arfelt KN, Smethurts C, Blanchard A, Jepras R, Rosenkilde MM.

FEBS Open Bio. 2013 Feb 19;3:156-60. doi: 10.1016/j.fob.2013.02.003. Print 2013.

17.

Epstein-Barr virus maintains lymphomas via its miRNAs.

Vereide DT, Seto E, Chiu YF, Hayes M, Tagawa T, Grundhoff A, Hammerschmidt W, Sugden B.

Oncogene. 2014 Mar 6;33(10):1258-64. doi: 10.1038/onc.2013.71. Epub 2013 Mar 18.

18.

Quantification of Epstein-Barr virus DNA in patients with idiopathic orbital inflammatory pseudotumor.

Jin R, Zhao P, Ma X, Ma J, Wu Y, Yang X, Zhang J, Zhong R, Zeng Y.

PLoS One. 2013;8(1):e50812. doi: 10.1371/journal.pone.0050812. Epub 2013 Jan 2.

19.

Molecular mechanisms deployed by virally encoded G protein-coupled receptors in human diseases.

Montaner S, Kufareva I, Abagyan R, Gutkind JS.

Annu Rev Pharmacol Toxicol. 2013;53:331-54. doi: 10.1146/annurev-pharmtox-010510-100608. Epub 2012 Oct 22. Review.

20.

Molecular characterization of oxysterol binding to the Epstein-Barr virus-induced gene 2 (GPR183).

Benned-Jensen T, Norn C, Laurent S, Madsen CM, Larsen HM, Arfelt KN, Wolf RM, Frimurer T, Sailer AW, Rosenkilde MM.

J Biol Chem. 2012 Oct 12;287(42):35470-83. doi: 10.1074/jbc.M112.387894. Epub 2012 Aug 8.

Supplemental Content

Support Center